Cyclin I-Cdk5 governs survival in post-mitotic cells

Cell Cycle

Volumn 9, Issue 9, 2010, Pages 1729-1731

  Brinkkoetter, Paul T ^a,b   Pippin, Jeffrey W ^a   Shankland, Stuart J ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Apoptosis; Bcl 2; Cyclin I; Cyclin dependent kinase 5; p35

Indexed keywords

CYCLIN DEPENDENT KINASE 5; CYCLIN I; CYCLINE; PROTEIN BCL 2; PROTEIN HYDROLYSATE; UNCLASSIFIED DRUG;

APOPTOSIS; CELL CYCLE; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; DOWNSTREAM PROCESSING; MITOSIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PURKINJE CELL; REGULATORY MECHANISM; REVIEW;

EID: 77953593623     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.9.11471     Document Type: Review

References (33)

1. Rickert P, Seghezzi W, Shanahan F, Cho H, Lees E. Cyclin C/CDK8 is a novel CTD kinase associated with RNA polymerase II. Oncogene 1996; 12:5-7.
2. Feaver WJ, Svejstrup JQ, Henry NL, Kornberg RD. Relationship of CDK-activating kinase and RNA polymerase II CTD kinase TFIIH/TFIIK. Cell 1994; 79:1103-9.
3. Edwards MC, Wong C, Elledge SJ. Human cyclin K, a novel RNA polymerase II-associated cyclin possessing both carboxy-terminal domain kinase and Cdk-activating kinase activity. Mol Cell Biol 1998; 18:4291-300.
4. Sano M, Schneider MD. Cyclins that don't cycle - cyclin T/cyclin-dependent kinase-9 determines cardiac muscle cell size. Cell Cycle 2003; 2:99-104.
5. Griffin SV, Olivier JP, Pippin JW, Roberts JM, Shankland SJ. Cyclin I protects podocytes from apoptosis. J Biol Chem 2006; 281:28048-57.
6. Jensen MR, Audolfsson T, Factor VM, Thorgeirsson SS. In vivo expression and genomic organization of the mouse Cyclin I gene (Ccni). Gene 2000; 256:59-67.
7. Nakamura T, Sanokawa R, Sasaki YF, Ayusawa D, Oishi M, Mori N. Cyclin I: a new cyclin encoded by a gene isolated from human brain. Exp Cell Res 1995; 221:534-42.
8. 2: DNA damage inducible genes. Oncogene 1996; 13:1103-9.
9. Liu Y, Tang MK, Cai DQ, Li M, Wong WM, Chow PH, et al. Cyclin I and p53 are differentially expressed during the terminal differentiation of the postnatal mouse heart. Proteomics 2007; 7:23-32.
10. Dhavan R, Tsai LH. A decade of CDK5. Nat Rev Mol Cell Biol 2001; 2:749-59.
11. Nikolic M, Dudek H, Kwon YT, Ramos YF, Tsai LH. The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev 1996; 10:816-25.
12. Gupta A, Tsai LH. Cyclin-dependent kinase 5 and neuronal migration in the neocortex. Neurosignals 2003; 12:173-9.
13. Hallows JL, Chen K, DePinho RA, Vincent I. Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice. J Neurosci 2003; 23:10633-44.
14. Smith D. Cdk5 in neuroskeletal dynamics. Neurosignals 2003; 12:239-51.
15. Cheng K, Ip NY. Cdk5: a new player at synapses. Neurosignals 2003; 12:180-90.
16. Dhariwala FA, Rajadhyaksha MS. An unusual member of the Cdk family: Cdk5. Cell Mol Neurobiol 2008; 28:351-69.
17. Lazaro JB, Kitzmann M, Poul MA, Vandromme M, Lamb NJ, Fernandez A. Cyclin dependent kinase 5, cdk5, is a positive regulator of myogenesis in mouse C2 cells. J Cell Sci 1997; 110:1251-60.
18. Lilja L, Yang SN, Webb DL, Juntti-Berggren L, Berggren PO, Bark C. Cyclin-dependent kinase 5 promotes insulin exocytosis. J Biol Chem 2001; 276:34199-205.
19. Tang XM, Strocchi P, Cambi F. Changes in the activity of cdk2 and cdk5 accompany differentiation of rat primary oligodendrocytes. J Cell Biochem 1998; 68:128-37.
20. Griffin SV, Hiromura K, Pippin J, Petermann AT, Blonski MJ, Krofft R, et al. Cyclin-dependent kinase 5 is a regulator of podocyte differentiation, proliferation and morphology. Am J Pathol 2004; 165:1175-85.
21. Rosales JL, Lee KY. Extraneuronal roles of cyclindependent kinase 5. Bioessays 2006; 28:1023-34.
22. Shetty KT, Kaech S, Link WT, Jaffe H, Flores CM, Wray S, et al. Molecular characterization of a neuronal-specific protein that stimulates the activity of Cdk5. J Neurochem 1995; 64:1988-95.
23. L in post-mitotic mouse cells. J Clin Invest 2009.
24. Ohshima T, Ward JM, Huh CG, Longenecker G, Veeranna, Pant HC, et al. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci USA 1996; 93:11173-8.
25. Ko J, Humbert S, Bronson RT, Takahashi S, Kulkarni AB, Li E, et al. p35 and p39 are essential for cyclindependent kinase 5 function during neurodevelopment. J Neurosci 2001; 21:6758-71.
26. Brinkkoetter PT, Wu JS, Ohse T, Krofft RD, Schermer B, Benzing T, et al. p35, the non-cyclin activator of Cdk5, protects podocytes against apoptosis in vitro and in vivo. Kidney Int.
27. Schnack C, Hengerer B, Gillardon F. Identification of novel substrates for Cdk5 and new targets for Cdk5 inhibitors using high-density protein microarrays. Proteomics 2008; 8:1980-6.
28. Brinkkoetter PT, Wu JS, Ohse T, Krofft RD, Schermer B, Benzing T, et al. p35, the non-cyclin activator of Cdk5, protects podocytes against apoptosis in vitro and in vivo. Kidney Int 2010.
29. Cheung ZH, Gong K, Ip NY. Cyclin-dependent kinase 5 supports neuronal survival through phosphorylation of Bcl-2. J Neurosci 2008; 28:4872-7.
30. Harada T, Morooka T, Ogawa S, Nishida E. ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1. Nat Cell Biol 2001; 3:453-9.
31. Sharma P, Veeranna, Sharma M, Amin ND, Sihag RK, Grant P, et al. Phosphorylation of MEK1 by cdk5/p35 downregulates the mitogen-activated protein kinase pathway. J Biol Chem 2002; 277:528-34.
32. Zheng YL, Li BS, Kanungo J, Kesavapany S, Amin N, Grant P, et al. Cdk5 Modulation of mitogenactivated protein kinase signaling regulates neuronal survival. Mol Biol Cell 2007; 18:404-13.
33. Wang CX, Song JH, Song DK, Yong VW, Shuaib A, Hao C. Cyclin-dependent kinase-5 prevents neuronal apoptosis through ERK-mediated upregulation of Bcl-2. Cell Death Differ 2006; 13:1203-12.